Pertuzumab in Combination with Trastuzumab and Docetaxel in the Neoadjuvant Treatment for Her2-Positive Breast Cancer

AuthID
P-00Y-N89
10
Author(s)
Vieira, C
·
Borges, A
·
Pereira, FF
·
Antunes, P
·
Redondo, P
·
Antunes, L
·
Borges, M
·
Bento, MJ
Tipo de Documento
Article
Year published
2023
Publicado
in Journal of Immunotherapy and Precision Oncology, ISSN: 2666-2345
Volume: 6, Número: 1, Páginas: 1-9
Indexing
Publication Identifiers
SCOPUS: 2-s2.0-85163178951
Source Identifiers
ISSN: 2666-2345
Export Publication Metadata
Citações
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.



CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info
At this moment we don't have any links to full text documens.